Showing results (261-270 of 693) with videos related to
Sort By:
Pageof 70
Diabetes & Metabolism|January 3, 2015
Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidenceA J Scheen, N PaquotRevue Medicale De Liege|January 11, 2020
[Which injectable therapy after failure of oral antidiabetic agents in type 2 diabetes ?]A J Scheen, N PaquotRevue Medicale De Liege|February 2, 2018
[SGLT2 inhibitor or GLP-1 receptor agonist in a patient with type 2 diabetes and cardiovascular disease ?]A J Scheen, N PaquotRevue Medicale De Liege|March 8, 2021
[SGLT2 inhibitors in patients with chronic kidney disease : from clinical trials to guidelines and new prospects for clinical practice]A J Scheen, P DelanayeRevue Medicale De Liege|August 16, 2012
[Role of psychosocial stress in complex diseases]G Scantamburlo, A J ScheenRevue Medicale De Liege|March 14, 2003
[The PROSPER Study (PROspective study of pravastatin in the elderly at risk)]H Kulbertus, A J ScheenDiabetes & Metabolism|January 11, 2003
New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistatA J Scheen, Ph ErnestRevue Medicale De Liege|August 28, 2003
[Blood glucose control and prevention of microangiopathy and macroangiopathy in type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|November 19, 2020
[Pharmacological therapies against COVID-19 : state of the art, between hopes and disappointments]A J Scheen, M MoutschenRevue Medicale De Liege|November 5, 2013
[Metformin, an antidiabetic molecule with anti-cancer properties]E Beck, A J ScheenPageof 70